About Hemanshu Pandya
Form D filings for Intrommune Therapeutics in 2024 list Hemanshu Pandya as director.
Hemanshu Pandya first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Hemanshu Pandya in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Hemanshu Pandya works with at each company, as listed on that company's latest Form D.
Intrommune Therapeutics, Inc. · Form D, Jan 22, 2024
EB
Erick Berglund
Director
JR
Jonathan Rich
Director
MN
Michael Nelson
President and director
WR
William Reisacher
Director